BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1920849)

  • 1. [Infection and protected environment].
    Funada H
    Rinsho Byori; 1991 Jul; Suppl 90():115-26. PubMed ID: 1920849
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.
    Schmeiser T; Kurrle E; Arnold R; Heit W; Krieger D; Kubanek B; Heimpel H
    Prog Clin Biol Res; 1985; 181():433-5. PubMed ID: 3895247
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression, graft-versus-host disease, and infection after bone marrow transplantation.
    Kramer BS; Elfenbein GJ
    J Fla Med Assoc; 1984 May; 71(5):321-8. PubMed ID: 6429272
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with protective isolation for infection prevention in the compromised host.
    Nagao T
    Tokai J Exp Clin Med; 1986; 11 Suppl():23-8. PubMed ID: 3132751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections in bone marrow transplant recipients.
    van der Meer JW; Guiot HF; van den Broek PJ; van Furth R
    Semin Hematol; 1984 Apr; 21(2):123-40. PubMed ID: 6204385
    [No Abstract]   [Full Text] [Related]  

  • 6. Total intestinal decontamination for prevention of infection in bone marrow transplantation.
    Funada H; Teshima H; Hattori K
    Jpn J Clin Oncol; 1983; 13 Suppl 1():111-26. PubMed ID: 6339774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective or complete elimination of the endogenous flora during allogeneic bone marrow transplantation?
    Guiot HF; van der Meer JW; Zwaan FE; Mulder CJ; Biemond J; Klasen EC
    Prog Clin Biol Res; 1985; 181():429-32. PubMed ID: 3895246
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation: current perspectives and future directions.
    Cheson BD; Curt GA
    J Natl Cancer Inst; 1986 Jun; 76(6):1265-7. PubMed ID: 3012181
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow transplantation.
    Nuscher R; Baltzer L; Repinec DA; Almquist G; Barrett JE; LaBombardi S; DeMao JD; Diver ME; Field BA; Lee MC
    Am J Nurs; 1984 Jun; 84(6):764-72. PubMed ID: 6375375
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of thalassemia by allogeneic bone marrow transplantation.
    Di Bartolomeo P; Di Girolamo G; Angrilli F; Bavaro P; Olioso P; Papalinetti G; Accorsi P; Quaglietta AM; Papola F; Adorno D
    Bone Marrow Transplant; 1993; 12 Suppl 1():37-41. PubMed ID: 8374558
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of bacterial and fungal infections in bone marrow transplant recipients and other granulocytopenic patients.
    Heidt PJ
    Cancer Detect Prev; 1988; 12(1-6):609-19. PubMed ID: 3052842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogenic transplantation of bone marrow in hematologic diseases. Preparation and completion of transplantation at the Hematology Clinic in Novi Sad].
    Pejin D; Popović S; Dokić M; Felle D; Stefanović N
    Acta Chir Iugosl; 1990; 37 Suppl 1():11-5. PubMed ID: 2109441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious complications of bone marrow transplantation.
    Winston DJ; Ho WG; Champlin RE; Gale RP
    Exp Hematol; 1984 Mar; 12(3):205-15. PubMed ID: 6368256
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow transplantation. III. Major problems and future directions.
    Spruce WE
    Am J Pediatr Hematol Oncol; 1983; 5(3):301-6. PubMed ID: 6414326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of infection in neutropenic bone marrow transplant patients.
    Rogers TR
    Antibiot Chemother (1971); 1985; 33():90-113. PubMed ID: 3922290
    [No Abstract]   [Full Text] [Related]  

  • 16. [Strategies for the prevention of infection in patients in situations of defensive deficit. The system used at the Hematologic Clinical Unit of the Clinica Puerta de Hierro (U.A.M.)].
    Fernández MN; Zabala P; Cabrera R; Sanjuan I; Barbolla L
    Sangre (Barc); 1985; 30(4-B):515-28. PubMed ID: 3936203
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of non-absorbable oral antibiotics in a simple reverse isolation environment for the prevention of infection in the immediate post-transplant period].
    Zabala P; Groiss J; Cabrera R; San Juan I; Barbolla L; Fernández MN
    Sangre (Barc); 1984; 29(4-A):423-8. PubMed ID: 6438818
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow transplantation: from last resort to preferred therapy.
    Jansen J; Provisor AJ; Vaughan J; Hoffman R
    Indiana Med; 1985 Apr; 78(4):265-9. PubMed ID: 3923097
    [No Abstract]   [Full Text] [Related]  

  • 19. [Protected environment-prophylactic antibiotic program for autologous bone marrow transplantation. Intestinal decontamination for infection prevention (author's transl)].
    Funada H; Teshima H; Hattori K
    Kansenshogaku Zasshi; 1981 Apr; 55(4):221-33. PubMed ID: 6793672
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation in children.
    Kato S; Yabe H; Yabe M; Hoshi N; Kimura M; Noguchi K; Arimori S; Tsuji K; Mori T; Yokoyama S
    Tokai J Exp Clin Med; 1986; 11 Suppl():43-7. PubMed ID: 2837836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.